A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference20 articles.
1. Current diagnosis and management of primary chylomicronemia;Okazaki;J Atheroscler Thromb,2021
2. Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia;Beigneux;N Engl J Med,2017
3. Anti-GPIHBP1 antibody-positive autoimmune hyperchylomicronemia and immune thrombocytopenia;Tanaka;J Atheroscler Thromb,2022
4. Acquired marked hypertriglyceridemia with anti-GPIHBP1 antibodies;Imai;Pediatr Int,2020
5. Chylomicronemia from GPIHBP1 autoantibodies successfully treated with rituximab: a case report;Lutz;Ann Intern Med,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia;Biomedicine & Pharmacotherapy;2023-12
2. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia;Journal of Clinical Lipidology;2023-11
3. Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes;Journal of Diabetes Investigation;2023-07-13
4. Eicosapentaenoic acid/pemafibrate;Reactions Weekly;2023-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3